Mimedx (MDXG) Asset Utilization Ratio (2011 - 2026)
Mimedx recorded quarterly Asset Utilization Ratio of 1.2 in Q1 2026, down 5.51% quarter-over-quarter from 1.27 in Q4 2025, and down 9.34% year-over-year from 1.32 in Q1 2025.
Mimedx's Asset Utilization Ratio history runs 15 years deep, the most recent figure standing at 1.2 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 9.34% year-over-year to 1.2; the TTM figure through Mar 2026 stood at 1.2 (down 9.34% YoY), while the FY2025 annual figure was 1.38, down 0.5% from the prior year.
- Asset Utilization Ratio came in at 1.2 for Q1 2026 at Mimedx, down from 1.27 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.71 in Q2 2023 to a low of 1.2 in Q1 2026.
- A 5-year average of 1.44 and a median of 1.43 in 2022 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio increased 24.28% in 2023 and fell 14.5% in 2024, its largest moves.
- Mimedx's Asset Utilization Ratio stood at 1.56 in 2022, then retreated by 3.48% to 1.5 in 2023, then fell by 8.52% to 1.37 in 2024, then retreated by 7.91% to 1.27 in 2025, then slipped by 5.51% to 1.2 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 1.2, 1.27, and 1.29 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.85 |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 1.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 |
| Dec 31, 2025 | 1.27 |
| Sep 30, 2025 | 1.29 |
| Jun 30, 2025 | 1.30 |
| Mar 31, 2025 | 1.32 |
| Dec 31, 2024 | 1.37 |
| Sep 30, 2024 | 1.45 |
| Jun 30, 2024 | 1.51 |
| Mar 31, 2024 | 1.45 |
| Dec 31, 2023 | 1.50 |
| Sep 30, 2023 | 1.69 |
| Jun 30, 2023 | 1.71 |
| Mar 31, 2023 | 1.65 |
| Dec 31, 2022 | 1.56 |
| Sep 30, 2022 | 1.43 |
| Jun 30, 2022 | 1.40 |
| Mar 31, 2022 | 1.33 |
| Dec 31, 2021 | 1.31 |
| Sep 30, 2021 | 1.41 |
| Jun 30, 2021 | 1.38 |
| Mar 31, 2021 | 1.25 |
| Dec 31, 2020 | 1.20 |
| Sep 30, 2020 | 1.41 |
| Jun 30, 2020 | 1.81 |
| Mar 31, 2020 | 1.81 |
| Dec 31, 2019 | 1.73 |
| Sep 30, 2019 | 1.80 |
| Jun 30, 2019 | 2.26 |
| Mar 31, 2019 | 2.97 |
| Dec 31, 2017 | 2.14 |
| Sep 30, 2017 | 1.60 |
| Jun 30, 2017 | 1.46 |
| Mar 31, 2017 | 1.70 |
| Dec 31, 2016 | 1.64 |
| Sep 30, 2016 | 1.27 |
| Jun 30, 2016 | 1.19 |
| Mar 31, 2016 | 1.28 |
| Dec 31, 2015 | 1.43 |
| Sep 30, 2015 | 1.46 |
| Jun 30, 2015 | 1.45 |
| Mar 31, 2015 | 1.29 |
| Dec 31, 2014 | 1.14 |
| Sep 30, 2014 | 1.05 |
| Jun 30, 2014 | 0.91 |
| Mar 31, 2014 | 0.78 |
| Dec 31, 2013 | 0.91 |
| Sep 30, 2013 | 1.21 |
| Jun 30, 2013 | 1.11 |
| Mar 31, 2013 | 0.96 |
| Dec 31, 2012 | 0.79 |
| Sep 30, 2012 | 0.63 |
| Jun 30, 2012 | 0.49 |
| Mar 31, 2012 | 0.39 |
| Dec 31, 2011 | 0.31 |